Advicenne S.A. (EPA:ALDVI)
0.9590
+0.0150 (1.59%)
May 14, 2026, 5:05 PM CET
Advicenne Market Cap
Advicenne has a market cap or net worth of €13.37 million as of May 14, 2026. Its market cap has decreased by -38.43% in one year.
Market Cap
13.37M
Enterprise Value
31.03M
Revenue
7.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.96
Market Cap Chart
Since December 6, 2017, Advicenne's market cap has decreased from 112.04M to 13.37M, a decrease of -88.06%. That is a compound annual growth rate of -22.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 13.37M | -45.43% |
| Dec 31, 2025 | 24.51M | 1.30% |
| Dec 31, 2024 | 24.20M | -25.97% |
| Dec 29, 2023 | 32.68M | -28.00% |
| Dec 30, 2022 | 45.40M | -51.76% |
| Dec 31, 2021 | 94.11M | 11.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nicox | 33.00M |
| genOway Société anonyme | 22.13M |
| GenSight Biologics | 20.40M |
| Aelis Farma | 17.13M |
| Aton | 13.91M |
| Poxel | 13.70M |
| NFL Biosciences | 11.53M |
| Oncodesign Precision Medicine Société anonyme | 8.35M |